Lonza
Lonza sees continued recovery in third quarter
November 1, 2011Manufacturing and Production, Sales and Marketing Lonza, Q3, manufacturing and production
Revenue growth at contract manufacturing organisation Lonza in the third quarter was once again undermined by the strength of the …
Lonza signs regenerative medicine deal with Mesoblast
September 27, 2011Manufacturing and Production Lonza, Mesoblast, pharma manufacturing news
Lonza has entered into a strategic-level alliance with Mesoblast, a specialist in regenerative medicines, which could see the construction of …
Lonza profits slide as exchange rates bite
August 9, 2011Manufacturing and Production CMO, Lonza
A strong Swiss franc has pegged back first-half profits at fine chemical and contract manufacturer Lonza, although the company said …
Lonza wins another antibody contract
July 19, 2011Manufacturing and Production Immune Pharmaceuticals, Lonza, pharma manufacturing news
Lonza has won a contract to manufacture Immune Pharmaceuticals’ antibody-based drug for inflammatory disorders, bertilimumab, at its mammalian development and …
Lonza buys Arch Chemicals for $1.2 billion
July 12, 2011Manufacturing and Production Lonza, pharma manufacturing news
Swiss fine chemical and contract manufacturing company Lonza has agreed to buy Arch Chemicals of the USA for $1.2 billion …
Pharma manufacturing news in brief
May 31, 2011Manufacturing and Production Aurobindo Pharma, Gallus, Lonza, ProMetic, Unigene
This week’s round-up of pharmaceutical manufacturing news includes new contracts for ProMetic and Unigene, plus facility updates from Aurobindo, Gallus …
Lonza invests again in Visp high-potency capacity
May 17, 2011Manufacturing and Production APIs, HPAPIs, Lonza, manufacturing and production
Lonza has pushed further into the high-potency active pharmaceutical ingredient (HPAPI) sector with another round of investment at its manufacturing …
Lonza expands UK facility, bio business reports growth
April 13, 2011Manufacturing and Production, Research and Development, Sales and Marketing Benlysta, Lonza, Slough, manufacturing
Swiss contract manufacturer and fine chemicals company Lonza has said it plans to expand its biopharmaceutical production unit in Slough, …
Lonza wins two biomanufacturing contracts
March 22, 2011Manufacturing and Production Athera Biotechnologies, ENB-0040, Enobia Pharma, Lonza, PC-mAb, asfotase alfa, contract manufacturing, pharma, pharmaceuticals
Lonza has been awarded two contracts for biological drug candidates in quick succession, including a new deal that will make …
Pharma manufacturing news in brief
November 23, 2010Manufacturing and Production Alpah Biologics, Alpha Biologics, Kemwell, Lonza, Phil Taylor, Roche
Facility updates from Roche, Alpha Biologics, Kemwell and Reinnervate, new contract services from Lonza and Patheon, plus a milestone in …
Lonza says contract manufacturing business is recovering
November 2, 2010Manufacturing and Production API, Lonza, contract manufacturing, pharma manufacturing
Lonza said its contract manufacturing business seems to be enjoying a return to form in the third quarter, despite continued …
GSK paves way for biopharmaceuticals growth
September 9, 2010Research and Development GlaxoSmithKline, Lonza, biologics
GlaxoSmithKline has handed Swiss contract manufacturer Lonza a contract to produce clinical trial batches of five monoclonal antibodies that are …
Lonza buys Vivante to get bigger in biologics
August 31, 2010Manufacturing and Production Lonza, Vivante
Swiss contract manufacturer and fine chemicals firm Lonza has expanded its biologics production capacity with the purchase of US firm …
Cell therapy industry partnership launched
August 18, 2010Research and Development Genzyme, ISCT, Lonza, Roche
Pharma and biotech companies including Roche and Genzyme are to launch a series of initiatives to bolster progress in the …
Lonza boosts profit despite contract manufacturing downturn
July 23, 2010Manufacturing and Production 2010 financials, Lonza, Q2
Switzerland’s Lonza posted a healthy increase in profits in the first half of 2010, topping analysts’ expectations, although sales dipped …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
